生物标志物在静脉血栓栓塞症预防及治疗中的应用进展

张壶涵, 赵黎明, 刘道城

武警医学 ›› 2026, Vol. 37 ›› Issue (3) : 267-270.

PDF(972 KB)
PDF(972 KB)
武警医学 ›› 2026, Vol. 37 ›› Issue (3) : 267-270. DOI: 10.3969/j.issn.1004-3594.2026.03.019
综述

生物标志物在静脉血栓栓塞症预防及治疗中的应用进展

  • 张壶涵1, 赵黎明1, 刘道城2
作者信息 +
文章历史 +

摘要

静脉血栓栓塞症(VTE)作为临床中常见的多病因疾病,不仅延迟患者伤病的康复,而且还会带来致残、致死风险。临床除了依据D-二聚体、凝血功能检查实现VTE的早期预防外,仍需进一步探索更早、更精准的检测方法。本文综述了常用生物标志物和一些新技术,为临床预防和治疗提供更多参考。

关键词

静脉血栓栓塞症 / 生物标志物 / 临床应用

引用本文

导出引用
张壶涵, 赵黎明, 刘道城. 生物标志物在静脉血栓栓塞症预防及治疗中的应用进展[J]. 武警医学. 2026, 37(3): 267-270 https://doi.org/10.3969/j.issn.1004-3594.2026.03.019
中图分类号: R446   

参考文献

[1] 何进椅, 赵丽岩, 丁敏辉, 等. 静脉血栓栓塞症的流行病学与临床研究进展[J]. 中国心血管杂志, 2024, 29(6): 585-588.
[2] Ji Y, Qin Y, Tan Q, et al.Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer[J]. BMC Biotechnol, 2024, 24(1): 30.
[3] Navarrete S, Solar C, Tapia R, et al. Pathophysiology of deep vein thrombosis[J]. Clin Exp Med, 2023, 23(3): 645-654.
[4] Yang D, Chen S, Zhuo C, et al.Analysis of risk factors for postoperative deep vein thrombosis in traumatic spinal fracture complicated with spinal cord injury[J].Clin Appl Thromb Hemost,2024,30: 10760296241271331.
[5] Sang Y, Roest M, de Laat B, et al. Interplay between platelets and coagulation[J]. Blood Rev, 2021, 46: 100733.
[6] 苏新宇, 靳 松, 谢学猛. 红细胞与静脉血栓栓塞症研究进展[J]. 中华老年心脑血管病杂志, 2023, 25(5): 550-552.
[7] Ma J, Qin J, Hu J, et al. Incidence and hematological biomarkers associated with preoperative deep venous thrombosis following foot fractures[J]. Foot Ankle Int, 2020, 41(12): 1563-1570.
[8] Chen X, Fan Y, Tu H, et al. A nomogram model based on the systemic immune-inflammation index to predict the risk of venous thromboembolism in elderly patients after hip fracture: a retrospective cohort study[J]. Heliyon, 2024, 10(6): e28389.
[9] 中华医学会骨科学分会创伤骨科学组, 中华医学会骨科学分会外固定与肢体重建学组, 中国医师协会骨科医师分会创伤专家工作委员会, 等. 中国创伤骨科患者围手术期静脉血栓栓塞症预防指南(2021)[J]. 中华创伤骨科杂志, 2021, 23(3): 185-192.
[10] Gaffney P J, Lane D A, Kakkar V V, et al. Characterisation of a soluble D dimer-E complex in crosslinked fibrin digests[J]. Thromb Res, 1975, 7(1): 89-99.
[11] Kitamura F, Shiraishi Y, Sakata K, et al.Screening for deep vein thrombosis using D-dimer levels based on surgical patients’ characteristics[J]. Cureus, 2024, 16(12): e75565.
[12] Stevens S M, Woller S C, Kreuziger L B, et al. Antithrombotic therapy for VTE disease: Second update of the Chest guideline and expert panel report[J]. Chest, 2021, 160(6): e545-e608.
[13] 中国研究型医院学会血栓与止血专业委员会. D-二聚体实验室检测与临床应用中国专家共识[J]. 中华医学杂志, 2023, 103(35): 2743-2756.
[14] Cox C, Roberts L N. Basics of diagnosis and treatment of venous thromboembolism[J]. J Thromb Haemost, 2025, 23(4): 1185-1202.
[15] 张 健, 李 勇. D-二聚体/纤维蛋白原比值与老年腰椎间盘突出患者术后下肢深静脉血栓的关系[J]. 中国老年学杂志, 2025, 45(24): 5982-5985.
[16] 宣 言, 王慕宁, 常思瑶, 等. 血栓四项在静脉血栓栓塞症中的应用进展[J]. 中华血管外科杂志(中英文), 2025, 10(3): 229-234.
[17] Lin Z, Sun H, Li D, et al. Thrombin antithrombin complex concentration as an early predictor of deep vein thrombosis after total hip arthroplasty and total knee arthroplasty[J]. BMC Musculoskelet Disord, 2022, 23(1): 574.
[18] Zhang W, Su Y, Liu L, et al. Fibrinolysis index as a new predictor of deep vein thrombosis after traumatic lower extremity fractures[J]. Clin Chim Acta, 2020, 511: 227-234.
[19] 赵 婷, 孙颖昕, 张武文, 等. 骨创伤患者发生下肢深静脉血栓的危险因素及其诊断效能分析[J]. 中华创伤杂志, 2024, 40(9): 809-816.
[20] 常冬华, 郭俊芳, 靳莎莎, 等. 血清总胆红素、尿酸、同型半胱氨酸水平与冠心病病情的相关性[J]. 中国实用医刊, 2025, 52(6): 38-41.
[21] Rallidis L S, Kosmas N, Rallidi T, et al. Homocysteine is an independent predictor of long-term cardiac mortality in patients with stable coronary artery disease in the era of statins[J]. Coron Artery Dis, 2020, 31(2): 152-156.
[22] Aday A W, Duran E K, Van Denburgh M, et al. Homocysteine is associated with future venous thromboembolism in 2 prospective cohorts of women[J]. Arterioscler Thromb Vasc Biol, 2021, 41(7): 2215-2224.
[23] Arachchillage D J, Platton S, Hickey K, et al. Guidelines on the investigation and management of antiphospholipid syndrome[J]. Br J Haematol, 2024, 205(3): 855-880.
[24] Nossent J C, Keen H I, Preen D B, et al. Long-term incidence, risk factors and complications for venous thromboembolism in patients with systemic lupus erythematosus[J]. Lupus, 2024, 33(8): 787-796.
[25] Colling M E, Ay C, Kraemmer D, et al. Lupus anticoagulant test persistence over time and its associations with future thrombotic events[J]. Blood Adv, 2022, 6(10): 2957-2966.
[26] Sennett C, Pula G. Trapped in the NETs: Multiple roles of platelets in the vascular complications associated with neutrophil extracellular traps[J]. Cells, 2025, 14(5): 335.
[27] Yao W, Hu X, Wang X. Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases[J]. Signal Transduct Target Ther, 2024, 9(1): 232.
[28] Tu Z, Zhu Y, Gao W, et al. Tackling severe neutrophilic inflammation in airway disorders with functionalized nanosheets[J]. ACS Nano, 2024, 18(9): 7084-7097.
[29] Liu L, Zhang W, Su Y, et al. The impact of neutrophil extracellular traps on deep venous thrombosis in patients with traumatic fractures[J]. Clin Chim Acta, 2021, 519: 231-238.
[30] Smith P, Rosell A, Farm M, et al. Markers of neutrophil activation and neutrophil extracellular traps in diagnosing patients with acute venous thromboembolism: a feasibility study based on two VTE cohorts[J]. PLoS One, 2022, 17(7): e0270865.
[31] Alberro A, Iparraguirre L, Fernandes A, et al. Extracellular vesicles in blood: Sources, effects, and applications[J]. Int J Mol Sci, 2021, 22(15): 8163.
[32] Liang Y, Lehrich B M, Zheng S, et al. Emerging methods in biomarker identification for extracellular vesicle-based liquid biopsy[J]. J Extracell Vesicles, 2021, 10(7): e12090.
[33] Min L, Bao H, Bu F, et al. Machine-learning-assisted procoagulant extracellular vesicle barcode assay toward high-performance evaluation of thrombosis-induced death risk in cancer patients[J]. ACS Nano, 2023, 17(20): 19914-19924.
[34] Zang X, Li C, Wang Y, et al. Protein profile of circulating extracellular vesicles reveals biomarker candidates for diagnosis of post-traumatic deep vein thrombosis[J]. Clin Chim Acta, 2024, 561: 119721.
[35] 臧新伟, 吴 俊. 血浆微颗粒在静脉血栓凝血机制中的研究进展[J]. 中华检验医学杂志, 2023, 46(9): 977-982.
[36] Zang X, Su Y, Zhang W, et al. Hepatocyte-derived microparticles as novel biomarkers for the diagnosis of deep venous thrombosis in trauma patients[J]. Clin Appl Thromb Hemost, 2023, 29: 10760296231153400.
[37] Frazer-Abel A, Kirschfink M, Prohászka Z. Expanding horizons in complement analysis and quality control[J]. Front Immunol, 2021, 12: 697313.
[38] Iglesias M J, Sanchez-Rivera L, Ibrahim-Kosta M, et al. Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism[J]. Nat Commun, 2023, 14(1): 3280.
[39] 中华医学会血液学分会血栓与止血学组. 易栓症诊断与防治中国指南(2021年版)[J]. 中华血液学杂志, 2021, 42(11): 881-888.

基金

军队某课题资助

PDF(972 KB)

Accesses

Citation

Detail

段落导航
相关文章

/